Potent dual antagonists of endothelin and angiotensin II receptors derived from α-phenoxyphenylacetic acids (Part III)
- 8 June 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (11) , 1155-1158
- https://doi.org/10.1016/0960-894x(95)00186-w
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamideJournal of Medicinal Chemistry, 1994
- Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRFBritish Journal of Pharmacology, 1993
- Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistNature, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Endothelin ETA and ETB receptors mediate vascular smooth muscle contractionBritish Journal of Pharmacology, 1992
- The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivoBiochemical and Biophysical Research Communications, 1992
- Endothelin: a new challengeJournal of Medicinal Chemistry, 1992
- Venous smooth muscle contains vasoconstrictor ETB-like receptorsBiochemical and Biophysical Research Communications, 1992
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990